Page last updated: 2024-11-05

2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and HTLV-I Infections

2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide has been researched along with HTLV-I Infections in 1 studies

2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2H-tetrazolium hydroxide: structure given in first source

HTLV-I Infections: Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grassi, F1
Guimarães Corrêa, AB1
Mascarenhas, RE1
Galvão, B1
Séon-Méniel, B1
Schmidt, F1
Franck, X1
Hocquemiller, R1
Figadère, B1
Fournet, A1

Other Studies

1 other study available for 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and HTLV-I Infections

ArticleYear
Quinoline compounds decrease in vitro spontaneous proliferation of peripheral blood mononuclear cells (PBMC) from human T-cell lymphotropic virus (HTLV) type-1-infected patients.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2008, Volume: 62, Issue:7

    Topics: Cell Proliferation; Cell Survival; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; HTLV-I Infect

2008